Research report: The developmental trajectory of depression and its relationship with quality of life during the conventional treatment process for patients with depression

Depression symptoms measured during the first twelve weeks of routine antidepressant treatment reliably predict how patients’ quality of life will develop over the same period, according to a prospective longitudinal study published in the European Journal of Futures Research. The study followed 120 patients with first-episode depression through four assessments and found that the direction of influence runs from depression to quality of life, not the other way around. It also found that both variables change along curved trajectories: symptoms fall quickly early in treatment and then level off, while quality of life rises quickly at first and then stabilizes.

A Harman single-factor test indicated no significant common method bias, with the first common factor accounting for 27.574 percent of the variance.

The descriptive results showed that from baseline to week 12, depression levels decreased while quality of life scores increased, and the two variables were significantly negatively correlated at all four measurements, with correlation coefficients ranging from −0.126 to −0.432. Age was significantly negatively correlated with depression from week 4 onward. Both the depression-to-quality-of-life model and the full model fit significantly better than the baseline, but the two did not differ significantly from each other, so the simpler model with only the depression-to-quality-of-life path was retained.

In that final model, depression at baseline significantly predicted quality of life at week 4 (β = −0.169, p = 0.027), depression at week 4 predicted quality of life at week 8 (β = −0.067, p = 0.002), and depression at week 8 predicted quality of life at week 12 (β = −0.071, p = 0.028). The reverse pathways, from quality of life to later depression, were not significant. The authors interpret this as evidence that during routine treatment, the severity of depressive symptoms is the temporally leading factor shaping how patients’ quality of life evolves, although the models describe associations at the level of the sample rather than proving causation within individuals.

For depression, the unconditional linear model showed an initial mean level of 17.740 and a linear slope of −4.068, confirming a steady average decline across the four measurements. Individual differences were significant in the initial level but not in the rate of change, and the correlation between a patient’s starting severity and their subsequent rate of improvement was not significant, meaning that patients with different baseline severities followed broadly similar treatment trajectories. For quality of life, the linear model showed an initial mean of 40.942 and a slope of 4.644, with significant individual variation in both starting points and rates of change. Patients who began with lower quality of life gained it faster, reflected in a significant negative intercept-slope correlation of −0.367.

Because elevated RMSEA values in the linear models hinted at non-linearity, the researchers added quadratic components. These models fit better for both variables and showed significant quadratic slopes, indicating that the pace of change was not constant over time. Depressive symptoms declined sharply during the first four weeks and then decelerated, approaching a plateau by week 12, while quality of life improved rapidly early in treatment and subsequently leveled off. Finally, a parallel process growth model linked the two trajectories: the initial level of depression significantly negatively predicted the initial level of quality of life (β = −0.499, p < 0.001), and the rate of depression reduction significantly predicted the rate of quality of life growth (β = −0.238, p < 0.001), so patients whose symptoms fell faster also saw faster functional improvement. The initial level of depression did not significantly predict the subsequent growth of quality of life.

The authors argue that these findings clarify a relationship that earlier cross-sectional and single-time-point studies had left ambiguous. Prior work summarized in the paper reports that quality of life scores in depression are significantly negatively correlated with symptom severity, that even patients in clinical remission can retain quality-of-life impairments, and that low quality of life is associated with poorer treatment confidence, reduced medication compliance, and suicidal ideation. The new results suggest that assessing depressive symptom severity and its change over time can serve as a prospective indicator of patients’ quality of life, and that early symptom improvement may act as a readily quantifiable proxy for broader functional recovery in first-episode, treatment-naive patients, a group the authors distinguish from the more chronic samples in some earlier studies.

The study’s limitations are explicit. The findings apply only to the acute phase of routine treatment and may not generalize to maintenance or rehabilitation phases, where the associations may take different, non-linear forms. The single-center design and limited sample coverage restrict generalizability and precluded in-depth gender subgroup analyses. Potential confounders such as antidepressant type and social support were not included in the parallel growth model, and the cross-lagged and parallel growth analyses describe sample-level associations; the authors recommend that future studies with larger samples apply random-intercept cross-lagged panel models to separate within-person change from stable between-person differences. Within those bounds, the study offers a dynamic picture of early treatment: symptoms lead, function follows, and both move fastest in the first weeks.

Subject of Research: Longitudinal trajectories of depression and quality of life during routine antidepressant treatment

Article Title: The developmental trajectory of depression and its relationship with quality of life during the conventional treatment process for patients with depression

Article References: Hou, X., Duan, X., Cao, K., Wu, W., Liu, Z., Fan, X., & Wang, Y. (2026). The developmental trajectory of depression and its relationship with quality of life during the conventional treatment process for patients with depression. European Journal of Futures Research, 14(1), Article 40. https://doi.org/10.1186/s40309-026-00304-9

Image Credits: AI Generated

DOI: 10.1186/s40309-026-00304-9

Keywords: depression, quality of life, longitudinal study, cross-lagged model, latent growth curve, antidepressant treatment, first-episode depression, HAMD-24, WHOQOL-BREF, treatment trajectory, psychiatry, developmental